Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Eczema/Dermatitis and Dermal Pruritus (MK-4117-202)

NCT01916980 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Eczema
Dermatitis
Dermal Pruritus

Interventions

DRUG: Desloratadine 5 mg

Sponsor

Organon and Co